1	By	by	IN	_	7	prep	7:AM-MNR
2	using	use	VBG	pb=use.01	1	pcomp	_
3	this	this	DT	_	4	det	_
4	website	website	NN	_	2	dobj	2:A1=PPT
5	,	,	,	_	7	punct	_
6	you	you	PRP	_	7	nsubj	7:A0=PAG
7	consent	consent	VBP	p2=NN|pb=consent.01	0	root	_
8	to	to	IN	_	7	prep	7:A1=GOL
9	our	our	PRP$	_	10	poss	_
10	use	use	NN	_	8	pobj	_
11	of	of	IN	_	10	prep	_
12	cookies	cookie	NNS	_	11	pobj	_
13	.	.	.	_	7	punct	_

1	For	for	IN	_	6	prep	6:AM-TMP
2	more	more	JJR	_	3	amod	_
3	information	information	NN	_	1	pobj	_
4	on	on	IN	_	3	prep	_
5	cookies	cookie	NNS	_	4	pobj	_
6	see	see	VBP	p2=VB|pb=see.01	0	root	_
7	our	our	PRP$	_	9	poss	_
8	Cookie	cookie	NNP	_	9	nn	_
9	Policy	policy	NNP	_	6	dobj	6:A1
10	.	.	.	_	6	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	nsubj	3:A0=PAG;14:A0
2	has	have	VBZ	_	3	aux	_
3	rejected	reject	VBN	pb=reject.01	0	root	_
4	a	a	DT	_	10	det	_
5	sweetened	sweeten	VBN	p2=JJ|pb=sweeten.02	10	amod	_
6	and	and	CC	_	5	cc	_
7	"	"	``	_	10	punct	_
8	final	final	JJ	_	10	amod	_
9	"	"	''	_	10	punct	_
10	offer	offer	NN	p2=VBP	3	dobj	3:A1=PPT;5:A1=PPT
11	from	from	IN	_	10	prep	_
12	Pfizer	pfizer	NNP	_	11	pobj	_
13	,	,	,	_	3	punct	_
14	leaving	leave	VBG	pb=leave.01	3	advcl	3:AM-PRD
15	it	it	PRP	_	14	dobj	14:A1=DIR
16	uncertain	uncertain	JJ	_	14	oprd	14:A2=PRD
17	if	if	IN	_	22	mark	_
18	the	the	DT	_	20	det	_
19	US	us	NNP	_	20	nn	_
20	drugmaker	drugmaker	NN	p2=NNP	22	nsubj	22:A0=PAG
21	would	would	MD	_	22	aux	22:AM-MOD
22	pull	pull	VB	pb=pull.01	14	advcl	_
23	off	off	RP	_	22	prt	22:C-V
24	its	its	PRP$	_	25	poss	_
25	plan	plan	NN	_	22	dobj	22:A1=PPT
26	to	to	TO	_	27	aux	_
27	create	create	VB	pb=create.01	25	infmod	_
28	the	the	DT	_	29	det	_
29	world	world	NN	_	33	poss	_
30	's	's	POS	_	29	possessive	_
31	biggest	big	JJS	_	33	amod	_
32	pharmaceuticals	pharmaceutical	NNS	_	33	nn	_
33	group	group	NN	_	27	dobj	27:A1=PPT
34	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	rebuff	rebuff	NN	_	3	nsubj	3:A1=PPT
3	came	come	VBD	pb=come.01	0	root	_
4	nine	#crd#	CD	_	5	num	_
5	hours	hour	NNS	_	8	npadvmod	_
6	after	after	IN	_	8	mark	_
7	Pfizer	pfizer	NNP	_	8	nsubj	8:A0
8	said	say	VBD	pb=say.01	3	advcl	3:AM-TMP
9	yesterday	yesterday	NN	_	8	npadvmod	8:AM-TMP
10	it	it	PRP	_	12	nsubj	12:A0=PAG
11	had	have	VBD	_	12	aux	_
12	raised	raise	VBN	pb=raise.01	8	ccomp	8:A1=PPT
13	its	its	PRP$	_	15	poss	_
14	takeover	takeover	NN	_	15	nn	_
15	offer	offer	NN	p2=VBP	12	dobj	12:A1=PPT
16	to	to	TO	p2=IN	17	aux	_
17	£55	£0	VB	pb=£0.01	12	advcl	12:AM-PNC
18	a	a	DT	_	19	det	_
19	share	share	NN	_	17	dobj	17:A1
20	,	,	,	_	12	punct	_
21	or	or	CC	_	19	cc	_
22	around	around	IN	p2=RB	12	prep	_
23	£70	£0	CD	p2=NN	24	number	_
24	billion	#crd#	CD	_	22	pobj	_
25	in	in	IN	_	24	prep	_
26	total	total	NN	p2=JJ	25	pobj	_
27	,	,	,	_	3	punct	_
28	and	and	CC	_	3	cc	_
29	would	would	MD	_	30	aux	30:AM-MOD
30	walk	walk	VB	pb=walk.01	3	conj	_
31	away	away	RB	_	30	advmod	30:AM-DIR
32	if	if	IN	_	36	mark	_
33	AstraZeneca	astrazeneca	NNP	_	36	nsubj	36:A0=PAG
34	did	do	VBD	_	36	aux	_
35	not	not	RB	_	36	neg	36:AM-NEG
36	accept	accept	VB	pb=accept.01	30	advcl	30:AM-ADV
37	it	it	PRP	_	36	dobj	36:A1=PPT
38	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG;4:A0=PAG
2	wants	want	VBZ	pb=want.01	0	root	_
3	to	to	TO	_	4	aux	_
4	create	create	VB	pb=create.01	2	xcomp	2:A1=PPT
5	the	the	DT	_	6	det	_
6	world	world	NN	_	10	poss	_
7	's	's	POS	_	6	possessive	_
8	largest	large	JJS	_	10	amod	_
9	drugs	drug	NNS	_	10	nn	_
10	company	company	NN	_	4	dobj	4:A1=PPT
11	,	,	,	_	4	punct	_
12	with	with	IN	_	4	prep	_
13	a	a	DT	_	14	det	_
14	headquarters	headquarters	NN	_	12	pobj	_
15	in	in	IN	_	14	prep	_
16	New	new	NNP	_	17	nn	_
17	York	york	NNP	_	15	pobj	_
18	but	but	CC	p2=IN	14	cc	_
19	a	a	DT	_	21	det	_
20	tax	tax	NN	_	21	nn	_
21	base	base	NN	_	14	conj	_
22	in	in	IN	_	21	prep	_
23	Britain	britain	NNP	_	22	pobj	29:AM-LOC
24	,	,	,	_	23	punct	_
25	where	where	WRB	_	29	advmod	29:R-AM-LOC
26	corporate	corporate	JJ	_	28	amod	_
27	tax	tax	NN	_	28	nn	_
28	rates	rate	NNS	_	29	nsubj	29:A1=PPT
29	are	be	VBP	pb=be.01	23	rcmod	_
30	lower	low	JJR	_	29	acomp	29:A2=PRD
31	than	than	IN	_	30	prep	_
32	in	in	IN	_	31	prep	_
33	the	the	DT	_	35	det	_
34	United	united	NNP	_	35	nn	_
35	States	states	NNP	_	32	pobj	_
36	.	.	.	_	2	punct	_

1	It	it	PRP	_	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	met	meet	VBN	pb=meet.01	0	root	_
4	entrenched	entrenched	JJ	_	5	amod	_
5	opposition	opposition	NN	_	3	dobj	3:A1=PPT
6	from	from	IN	_	5	prep	_
7	AstraZeneca	astrazeneca	NNP	_	6	pobj	_
8	,	,	,	_	5	punct	_
9	as	as	RB	_	11	advmod	_
10	well	well	RB	_	11	advmod	_
11	as	as	IN	_	5	cc	_
12	many	many	JJ	_	13	amod	_
13	politicians	politician	NNS	_	5	conj	_
14	and	and	CC	_	13	cc	_
15	scientists	scientist	NNS	_	13	conj	17:A0=PPT
16	who	who	WP	p2=VBP	17	nsubj	17:R-A0
17	fear	fear	VBP	pb=fear.01	15	rcmod	_
18	cuts	cut	NNS	_	17	dobj	17:A1=PAG
19	to	to	IN	_	17	prep	_
20	jobs	job	NNS	_	19	pobj	_
21	and	and	CC	_	20	cc	_
22	research	research	NN	_	20	conj	_
23	.	.	.	_	3	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=NN	2	nn	_
2	chairman	chairman	NN	_	4	nn	_
3	Leif	leif	NNP	_	4	nn	_
4	Johansson	johansson	NNP	_	5	nsubj	5:A0
5	said	say	VBD	pb=say.01	0	root	_
6	he	he	PRP	_	8	nsubj	8:A0=PAG
7	had	have	VBD	_	8	aux	_
8	made	make	VBN	pb=make.02	5	ccomp	5:A1=PPT
9	clear	clear	JJ	_	8	oprd	8:A1=PRD
10	in	in	IN	_	8	prep	8:AM-LOC
11	discussions	discussion	NNS	_	10	pobj	_
12	with	with	IN	_	11	prep	_
13	Pfizer	pfizer	NNP	_	12	pobj	_
14	that	that	IN	_	19	complm	_
15	his	his	PRP$	_	16	poss	_
16	board	board	NN	_	19	nsubj	19:A0=PAG
17	could	could	MD	_	19	aux	19:AM-MOD
18	only	only	RB	_	19	advmod	19:AM-ADV
19	recommend	recommend	VB	pb=recommend.01	8	ccomp	_
20	a	a	DT	_	21	det	_
21	bid	bid	NN	_	19	dobj	19:A1=PPT;23:A1=PPT
22	that	that	WDT	p2=DT	23	nsubj	23:R-A1
23	was	be	VBD	pb=be.01	21	rcmod	_
24	at	at	IN	p2=RB	25	advmod	_
25	least	least	JJS	p2=RBS	26	advmod	_
26	10	0	CD	_	28	num	_
27	per	per	NN	p2=IN	28	nn	_
28	cent	cent	NN	_	29	npadvmod	_
29	above	above	IN	p2=RB	23	prep	23:A2=PRD
30	an	an	DT	_	31	det	_
31	offer	offer	NN	_	29	pobj	_
32	of	of	IN	_	31	prep	_
33	£53.50	£0	NNS	p2=NN	32	pobj	34:A1=PRD
34	made	make	VBN	pb=make.01	33	partmod	_
35	by	by	IN	_	34	agent	34:A0=PAG
36	Pfizer	pfizer	NNP	_	35	pobj	_
37	on	on	IN	_	34	prep	34:AM-TMP
38	Friday	friday	NNP	_	37	pobj	_
39	,	,	,	_	38	punct	_
40	or	or	CC	_	38	cc	_
41	£58.85	£0	CD	p2=NN	38	conj	_
42	.	.	.	_	5	punct	_

1	In	in	IN	_	11	prep	11:AM-DIS
2	addition	addition	NN	_	1	pobj	_
3	to	to	IN	_	2	prep	_
4	the	the	DT	_	6	det	_
5	inadequate	inadequate	JJ	_	6	amod	_
6	price	price	NN	_	3	pobj	_
7	,	,	,	_	11	punct	_
8	Mr	mr	NNP	_	9	nn	_
9	Johansson	johansson	NNP	_	11	nsubj	11:A0=PAG
10	also	also	RB	_	11	advmod	11:AM-DIS
11	slammed	slam	VBD	pb=slam.01	0	root	_
12	the	the	DT	_	15	det	_
13	lack	lack	NN	p2=JJ	15	amod	_
14	industrial	industrial	JJ	_	15	amod	_
15	logic	logic	NN	_	11	dobj	11:A1=PPT
16	behind	behind	IN	_	15	prep	_
17	Pfizer	pfizer	NNP	p2=NN	19	poss	_
18	's	's	POS	_	17	possessive	_
19	move	move	NN	_	16	pobj	_
20	.	.	.	_	11	punct	_

1	"	"	``	_	10	punct	_
2	Pfizer	pfizer	NNP	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	approach	approach	NN	_	10	nsubj	10:A1=PPT;15:A1=PPT
5	throughout	throughout	IN	_	4	prep	_
6	its	its	PRP$	_	7	poss	_
7	pursuit	pursuit	NN	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	AstraZeneca	astrazeneca	NNP	_	8	pobj	_
10	appears	appear	VBZ	pb=appear.02	33	ccomp	33:A1=PPT
11	to	to	TO	_	15	aux	_
12	have	have	VB	_	15	aux	_
13	been	be	VBN	_	15	auxpass	_
14	fundamentally	fundamentally	RB	_	15	advmod	15:AM-MNR
15	driven	drive	VBN	pb=drive.02	10	xcomp	10:C-A1
16	by	by	IN	_	15	agent	15:A0=PAG
17	the	the	DT	_	20	det	_
18	corporate	corporate	JJ	_	20	amod	_
19	financial	financial	JJ	_	20	amod	_
20	benefits	benefit	NNS	_	16	pobj	_
21	to	to	IN	_	20	prep	_
22	its	its	PRP$	_	23	poss	_
23	shareholders	shareholder	NNS	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	cost	cost	NN	p2=JJ	26	nn	_
26	savings	saving	NNS	_	24	pobj	_
27	and	and	CC	_	26	cc	_
28	tax	tax	NN	_	29	nn	_
29	minimisation	minimisation	NN	_	26	conj	_
30	,	,	,	_	33	punct	_
31	"	"	''	_	33	punct	_
32	he	he	PRP	_	33	nsubj	33:A0
33	said	say	VBD	pb=say.01	0	root	_
34	.	.	.	_	33	punct	_

1	Pfizer	pfizer	NNP	_	4	poss	_
2	's	's	POS	_	1	possessive	_
3	proposed	propose	VBN	p2=JJ|pb=propose.01	4	amod	_
4	takeover	takeover	NN	_	6	nsubj	3:A1=PPT;6:A1=PPT;19:A1=PPT
5	would	would	MD	_	6	aux	6:AM-MOD
6	be	be	VB	pb=be.01	0	root	_
7	the	the	DT	_	12	det	_
8	largest	large	JJS	p2=RBS	10	hmod	_
9	-	-	HYPH	p2=,	10	hyph	_
10	ever	ever	RB	_	12	amod	_
11	foreign	foreign	JJ	_	12	amod	_
12	acquisition	acquisition	NN	_	6	attr	6:A2=PRD
13	of	of	IN	_	12	prep	_
14	a	a	DT	_	16	det	_
15	British	british	JJ	_	16	amod	_
16	company	company	NN	_	13	pobj	_
17	and	and	CC	_	6	cc	_
18	is	be	VBZ	_	19	auxpass	_
19	opposed	oppose	VBN	pb=oppose.01	6	conj	_
20	by	by	IN	_	19	agent	19:A0=PPT
21	many	many	JJ	_	22	amod	_
22	scientists	scientist	NNS	_	20	pobj	26:A0=PPT
23	and	and	CC	_	22	cc	_
24	politicians	politician	NNS	_	22	conj	_
25	who	who	WP	p2=TO	26	nsubj	26:R-A0
26	fear	fear	VBP	pb=fear.01	22	rcmod	_
27	it	it	PRP	_	29	nsubj	29:A0=PAG
28	would	would	MD	_	29	aux	29:AM-MOD
29	undermine	undermine	VB	pb=undermine.01	26	ccomp	26:A1=PAG
30	Britain	britain	NNP	_	33	poss	_
31	's	's	POS	_	30	possessive	_
32	science	science	NN	_	33	nn	_
33	base	base	NN	_	29	dobj	29:A1=PPT
34	.	.	.	_	6	punct	_

1	Analyst	analyst	NNP	_	3	nn	_
2	Tim	tim	NNP	_	3	nn	_
3	Anderson	anderson	NNP	_	7	nsubj	7:A0
4	at	at	IN	_	3	prep	_
5	brokerage	brokerage	NN	p2=NNP	6	nn	_
6	Bernstein	bernstein	NNP	_	4	pobj	_
7	said	say	VBD	pb=say.01	0	root	_
8	shares	share	NNS	_	12	nsubj	12:A1=PPT;16:A1=GOL
9	in	in	IN	_	8	prep	_
10	both	both	DT	_	11	det	_
11	companies	company	NNS	_	9	pobj	_
12	were	be	VBD	pb=be.01	7	ccomp	7:A1=PPT
13	likely	likely	JJ	_	12	acomp	12:A2=PRD
14	to	to	TO	_	16	aux	_
15	be	be	VB	_	16	auxpass	_
16	hit	hit	VBN	pb=hit.01	13	xcomp	_
17	if	if	IN	_	21	mark	_
18	the	the	DT	_	20	det	_
19	potential	potential	JJ	_	20	amod	_
20	deal	deal	NN	_	21	nsubj	21:A1=PPT
21	falls	fall	VBZ	pb=fall.06	16	advcl	16:AM-ADV
22	through	through	RP	p2=IN	21	prt	21:C-V
23	.	.	.	_	7	punct	_

1	The	the	DT	_	3	det	_
2	US	us	NNP	_	3	nn	_
3	group	group	NN	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	its	its	PRP$	_	7	poss	_
6	new	new	JJ	_	7	amod	_
7	offer	offer	NN	_	8	nsubj	8:A1=PPT;14:A1=PPT
8	was	be	VBD	pb=be.01	4	ccomp	4:A1=PPT
9	final	final	JJ	_	8	acomp	8:A2=PRD
10	and	and	CC	_	8	cc	_
11	could	could	MD	_	14	aux	14:AM-MOD
12	not	not	RB	_	14	neg	14:AM-NEG
13	be	be	VB	_	14	auxpass	_
14	increased	increase	VBN	pb=increase.01	8	conj	_
15	.	.	.	_	4	punct	_

1	It	it	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	it	it	PRP	_	6	nsubj	6:A0=PAG;17:A0=PAG
4	would	would	MD	_	6	aux	6:AM-MOD
5	not	not	RB	_	6	neg	6:AM-NEG
6	make	make	VB	pb=make.05	2	ccomp	2:A1=PPT
7	a	a	DT	_	9	det	_
8	hostile	hostile	JJ	_	9	amod	_
9	offer	offer	NN	_	6	dobj	6:AM-PRR
10	directly	directly	RB	_	6	advmod	6:AM-MNR
11	to	to	IN	p2=TO	6	prep	6:A2=DIR
12	AstraZeneca	astrazeneca	NNP	_	13	nn	_
13	shareholders	shareholder	NNS	_	11	pobj	_
14	and	and	CC	_	6	cc	_
15	would	would	MD	_	17	aux	17:AM-MOD
16	only	only	RB	_	17	advmod	17:AM-ADV
17	proceed	proceed	VB	pb=proceed.01	6	conj	_
18	with	with	IN	_	17	prep	17:A1=PPT
19	an	an	DT	_	20	det	_
20	offer	offer	NN	_	18	pobj	_
21	with	with	IN	_	20	prep	_
22	the	the	DT	_	23	det	_
23	recommendation	recommendation	NN	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	the	the	DT	_	27	det	_
26	AstraZeneca	astrazeneca	NNP	_	27	nn	_
27	board	board	NN	_	24	pobj	_
28	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	also	also	RB	_	3	advmod	3:AM-DIS
3	increased	increase	VBD	pb=increase.01	0	root	_
4	the	the	DT	_	6	det	_
5	cash	cash	NN	_	6	nn	_
6	element	element	NN	_	3	dobj	3:A1=PPT
7	in	in	IN	_	6	prep	_
8	its	its	PRP$	_	9	poss	_
9	offer	offer	NN	_	7	pobj	_
10	to	to	IN	_	3	prep	3:A4=GOL
11	45	0	CD	_	13	num	_
12	per	per	NN	p2=IN	13	nn	_
13	cent	cent	NN	_	10	pobj	_
14	,	,	,	_	3	punct	_
15	under	under	IN	_	20	prep	20:R-AM-LOC
16	which	which	WDT	_	15	pobj	_
17	AstraZeneca	astrazeneca	NNP	_	18	nn	_
18	shareholders	shareholder	NNS	_	20	nsubj	20:A0=PAG
19	would	would	MD	_	20	aux	20:AM-MOD
20	get	get	VB	pb=get.01	3	advcl	_
21	1.747	0	CD	_	22	num	_
22	shares	share	NNS	_	20	dobj	20:A1=PPT
23	in	in	IN	_	20	prep	20:A2=DIR
24	the	the	DT	_	26	det	_
25	enlarged	enlarged	JJ	p2=VBN	26	amod	_
26	company	company	NN	_	23	pobj	_
27	for	for	IN	_	20	prep	20:A3=VSP
28	each	each	DT	_	27	pobj	_
29	of	of	IN	_	28	prep	_
30	their	their	PRP$	_	32	poss	_
31	AstraZeneca	astrazeneca	NNP	p2=JJ	32	nn	_
32	shares	share	NNS	_	29	pobj	_
33	and	and	CC	_	20	cc	_
34	£24.76	£0	CD	p2=NNS	20	conj	_
35	in	in	IN	p2=RP	34	prep	_
36	cash	cash	NN	_	35	pobj	_
37	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	new	new	JJ	_	3	amod	_
3	offer	offer	NN	_	4	nsubj	4:A0=PAG
4	represents	represent	VBZ	pb=represent.01	0	root	_
5	a	a	DT	_	9	det	_
6	15	0	CD	_	8	num	_
7	per	per	NN	p2=FW	8	nn	_
8	cent	cent	NN	_	9	nn	_
9	premium	premium	NN	_	4	dobj	4:A1=PPT
10	over	over	IN	_	9	prep	_
11	the	the	DT	_	13	det	_
12	current	current	JJ	_	13	amod	_
13	value	value	NN	_	10	pobj	_
14	of	of	IN	_	13	prep	_
15	a	a	DT	_	21	det	_
16	cash	cash	NN	_	21	nn	_
17	-	-	HYPH	_	16	hyph	_
18	and	and	CC	_	16	cc	_
19	-	-	HYPH	_	20	hyph	_
20	share	share	NN	p2=VB	16	conj	_
21	approach	approach	NN	_	14	pobj	22:A1=PPT
22	made	make	VBN	p2=VBD|pb=make.05	21	partmod	_
23	on	on	IN	_	22	prep	22:AM-TMP
24	May	may	NNP	_	23	pobj	_
25	2	0	CD	_	27	hmod	_
26	-	-	HYPH	p2=:	27	hyph	_
27	worth	worth	NN	p2=JJ	28	nn	_
28	£50	£0	CD	p2=,	30	num	_
29	a	a	DT	_	30	det	_
30	share	share	NN	_	4	dobj	39:A1=PPT
31	at	at	IN	_	30	prep	_
32	the	the	DT	_	33	det	_
33	time	time	NN	_	31	pobj	_
34	-	-	,	p2=:	30	punct	_
35	which	which	WDT	_	39	nsubjpass	39:R-A1
36	was	be	VBD	_	39	auxpass	_
37	also	also	RB	_	39	advmod	_
38	swiftly	swiftly	RB	_	39	advmod	39:AM-MNR
39	rejected	reject	VBN	pb=reject.01	30	rcmod	_
40	by	by	IN	_	39	agent	39:A0=PAG
41	AstraZeneca	astrazeneca	NNP	_	40	pobj	_
42	.	.	.	_	4	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nn	_
2	chief	chief	JJ	_	3	amod	_
3	executive	executive	NN	_	5	nn	_
4	Ian	ian	NNP	_	5	nn	_
5	Read	read	NNP	_	6	nsubj	6:A0
6	said	say	VBD	pb=say.01	0	root	_
7	he	he	PRP	_	8	nsubj	8:A0=PAG
8	believed	believe	VBD	pb=believe.01	6	ccomp	6:A1=PPT
9	his	his	PRP$	_	10	poss	_
10	company	company	NN	_	12	poss	_
11	's	's	POS	_	10	possessive	_
12	proposal	proposal	NN	_	13	nsubj	21:A0=PAG;13:A1=PPT
13	was	be	VBD	pb=be.01	8	ccomp	8:A1=PPT
14	"	"	``	_	15	punct	_
15	compelling	compelling	JJ	p2=VBG	13	acomp	13:A2=PRD
16	"	"	''	_	15	punct	_
17	for	for	IN	_	15	prep	_
18	AstraZeneca	astrazeneca	NNP	_	19	nn	_
19	shareholders	shareholder	NNS	_	17	pobj	_
20	and	and	CC	_	13	cc	_
21	expressed	express	VBD	pb=express.01	13	conj	_
22	frustration	frustration	NN	_	21	dobj	21:A1=PPT
23	at	at	IN	_	22	prep	_
24	its	its	PRP$	_	25	poss	_
25	refusal	refusal	NN	_	23	pobj	_
26	to	to	TO	_	27	aux	_
27	engage	engage	VB	pb=engage.01	25	infmod	_
28	in	in	IN	_	27	prep	27:A2=PPT
29	talks	talk	NNS	_	28	pobj	_
30	,	,	,	_	21	punct	_
31	urging	urge	VBG	pb=urge.01	21	advcl	21:AM-ADV
32	the	the	DT	_	34	det	_
33	British	british	JJ	_	34	amod	_
34	company	company	NN	_	36	poss	_
35	's	's	POS	_	34	possessive	_
36	shareholders	shareholder	NNS	_	31	dobj	38:A0=PAG;42:A0=PAG;31:A1=PPT
37	to	to	TO	_	38	aux	_
38	pressure	pressure	VB	pb=pressure.01	31	xcomp	31:A2=PPT
39	its	its	PRP$	_	40	poss	_
40	board	board	NN	_	38	dobj	38:A1=PPT
41	to	to	TO	_	42	aux	_
42	start	start	VB	pb=start.01	38	advcl	38:A2=PRD
43	discussions	discussion	NNS	_	42	dobj	42:A1=PPT
44	.	.	.	_	6	punct	_

1	In	in	IN	_	27	prep	27:AM-LOC
2	the	the	DT	_	3	det	_
3	absence	absence	NN	_	1	pobj	_
4	of	of	IN	_	3	prep	_
5	further	far	JJ	_	6	amod	_
6	discussions	discussion	NNS	_	4	pobj	_
7	or	or	CC	_	6	cc	_
8	an	an	DT	_	9	det	_
9	extension	extension	NN	_	6	conj	_
10	of	of	IN	_	9	prep	_
11	the	the	DT	_	12	det	_
12	deadline	deadline	NN	_	10	pobj	_
13	for	for	IN	_	12	prep	_
14	making	make	VBG	pb=make.LV	13	pcomp	_
15	a	a	DT	_	17	det	_
16	firm	firm	JJ	p2=NN	17	amod	_
17	offer	offer	NN	_	14	dobj	14:AM-PRR
18	under	under	IN	_	17	prep	_
19	British	british	JJ	_	21	amod	_
20	takeover	takeover	NN	_	21	nn	_
21	rules	rule	NNS	_	18	pobj	_
22	,	,	,	_	27	punct	_
23	Pfizer	pfizer	NNP	_	25	poss	_
24	's	's	POS	_	23	possessive	_
25	proposal	proposal	NN	_	27	nsubj	27:A1=PPT
26	will	will	MD	_	27	aux	27:AM-MOD
27	expire	expire	VB	pb=expire.01	0	root	_
28	at	at	IN	_	27	prep	27:AM-TMP
29	5	0	CD	_	30	num	_
30	pm	pm	NN	p2=NNS	28	pobj	_
31	(	(	-LRB-	_	30	punct	_
32	1600	0	CD	_	33	num	_
33	GMT	gmt	NNP	p2=NN	30	appos	_
34	)	)	-RRB-	_	30	punct	_
35	on	on	IN	_	27	prep	27:AM-TMP
36	May	may	NNP	_	37	nn	_
37	26th	#ord#	NN	_	35	pobj	_
38	.	.	.	_	27	punct	_

1	The	the	DT	_	3	det	_
2	increased	increase	VBN	p2=VBD|pb=increase.01	3	amod	_
3	offer	offer	NN	_	7	nsubjpass	2:A1=PPT;7:A1=PPT
4	had	have	VBD	_	7	aux	_
5	been	be	VBN	_	7	auxpass	_
6	widely	widely	RB	_	7	advmod	7:AM-MNR
7	expected	expect	VBN	pb=expect.01	0	root	_
8	.	.	.	_	7	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	last	last	JJ	_	4	amod	_
4	week	week	NN	_	2	npadvmod	2:AM-TMP
5	it	it	PRP	_	7	nsubj	7:A0=PAG
6	would	would	MD	_	7	aux	7:AM-MOD
7	consider	consider	VB	pb=consider.01	2	ccomp	2:A1=PPT
8	a	a	DT	_	10	det	_
9	higher	high	JJR	_	10	amod	_
10	offer	offer	NN	_	7	dobj	7:A1
11	as	as	IN	_	13	mark	_
12	it	it	PRP	_	13	nsubj	13:A0=PAG
13	urged	urge	VBD	pb=urge.01	7	advcl	7:AM-TMP
14	AstraZeneca	astrazeneca	NNP	_	16	poss	_
15	's	's	POS	_	14	possessive	_
16	board	board	NN	_	13	dobj	18:A0=PPT;13:A1=PPT
17	to	to	TO	_	18	aux	_
18	enter	enter	VB	pb=enter.01	13	xcomp	13:A2=PPT
19	talks	talk	NNS	_	18	dobj	18:A1=LOC
20	.	.	.	_	2	punct	_

1	The	the	DT	_	3	det	_
2	British	british	JJ	_	3	amod	_
3	firm	firm	NN	_	5	nsubj	5:A0=PAG;15:A0=PAG
4	has	have	VBZ	_	5	aux	_
5	laid	lay	VBN	pb=lay.01	0	root	_
6	out	out	RP	_	5	prt	5:C-V
7	details	detail	NNS	_	5	dobj	5:A1=PPT
8	of	of	IN	_	7	prep	_
9	its	its	PRP$	_	10	poss	_
10	pipeline	pipeline	NN	_	8	pobj	_
11	of	of	IN	_	10	prep	_
12	new	new	JJ	_	13	amod	_
13	drugs	drug	NNS	_	11	pobj	_
14	and	and	CC	_	5	cc	_
15	argues	argue	VBZ	p2=NNS|pb=argue.01	5	conj	_
16	it	it	PRP	_	17	nsubj	17:A0=PAG
17	has	have	VBZ	p2=VBP|pb=have.03	15	ccomp	15:A1=PPT
18	no	no	DT	_	19	det	_
19	need	need	NN	_	17	dobj	17:A1=PPT
20	for	for	IN	_	19	prep	_
21	a	a	DT	_	22	det	_
22	deal	deal	NN	_	20	pobj	_
23	.	.	.	_	5	punct	_

1	Investors	investor	NNS	_	3	nsubj	3:A0=PAG;6:A0=PAG
2	have	have	VBP	_	3	aux	_
3	backed	back	VBN	pb=back.01	0	root	_
4	AstraZeneca	astrazeneca	NNP	_	3	dobj	3:A1=PPT
5	in	in	IN	_	3	prep	3:AM-MNR
6	rejecting	reject	VBG	pb=reject.01	5	pcomp	_
7	£50	£0	IN	p2=CD	6	prep	6:A1=PPT
8	a	a	DT	_	9	det	_
9	share	share	NN	_	7	pobj	_
10	,	,	,	_	3	punct	_
11	but	but	CC	_	3	cc	_
12	several	several	JJ	_	14	nsubj	14:A0
13	have	have	VBP	_	14	aux	_
14	said	say	VBN	pb=say.01	3	conj	_
15	they	they	PRP	_	17	nsubj	17:A0=PAG
16	would	would	MD	_	17	aux	17:AM-MOD
17	want	want	VB	pb=want.01	14	ccomp	14:A1=PPT
18	it	it	PRP	_	20	nsubj	20:A0=PAG
19	to	to	TO	_	20	aux	_
20	engage	engage	VB	pb=engage.01	17	ccomp	17:A1=PPT
21	in	in	IN	_	20	prep	20:A2=PPT
22	discussions	discussion	NNS	_	21	pobj	_
23	if	if	IN	_	25	mark	_
24	Pfizer	pfizer	NNP	_	25	nsubj	25:A1=PPT
25	came	come	VBD	pb=come.01	17	advcl	17:AM-ADV;20:AM-ADV
26	back	back	RB	p2=RP	25	advmod	25:AM-DIR
27	with	with	IN	_	25	prep	25:AM-MNR
28	an	an	DT	_	30	det	_
29	improved	improved	JJ	p2=VBN	30	amod	_
30	offer	offer	NN	_	27	pobj	_
31	.	.	.	_	14	punct	_

1	They	they	PRP	_	2	nsubj	2:A0=PPT
2	fear	fear	VBP	pb=fear.01	0	root	_
3	AstraZeneca	astrazeneca	NNP	p2=JJ	4	nn	_
4	shares	share	NNS	_	6	nsubj	6:A1
5	will	will	MD	_	6	aux	6:AM-MOD
6	tumble	tumble	VB	pb=tumble.01	2	ccomp	2:A1=PAG
7	if	if	IN	_	9	mark	_
8	Pfizer	pfizer	NNP	_	9	nsubj	9:A0=PPT
9	walks	walk	VBZ	pb=walk.01	6	advcl	6:AM-ADV
10	away	away	RB	_	9	advmod	9:AM-DIR
11	.	.	.	_	2	punct	_

1	There	there	EX	_	3	expl	_
2	has	have	VBZ	_	3	aux	_
3	been	be	VBN	pb=be.02	0	root	_
4	a	a	DT	_	7	det	_
5	mounting	mount	VBG	p2=JJ|pb=mount.02	7	amod	_
6	political	political	JJ	_	7	amod	_
7	backlash	backlash	NN	_	3	attr	3:A1=PPT;5:A1=PPT
8	against	against	IN	_	7	prep	_
9	the	the	DT	_	11	det	_
10	proposed	propose	VBN	p2=JJ|pb=propose.01	11	amod	_
11	deal	deal	NN	_	8	pobj	10:A1=PPT
12	in	in	IN	_	11	prep	_
13	Britain	britain	NNP	_	12	pobj	_
14	,	,	,	_	13	punct	_
15	the	the	DT	_	17	det	_
16	United	united	NNP	_	17	nn	_
17	States	states	NNP	_	13	conj	_
18	and	and	CC	_	17	cc	_
19	Sweden	sweden	NNP	_	17	conj	_
20	,	,	,	_	17	punct	_
21	where	where	WRB	_	23	advmod	23:R-AM-LOC
22	AstraZeneca	astrazeneca	NNP	_	23	nsubj	23:A0=PAG
23	has	have	VBZ	pb=have.03	17	rcmod	_
24	half	half	PDT	p2=VBN	26	predet	_
25	its	its	PRP$	_	26	poss	_
26	roots	root	NNS	_	23	dobj	23:A1=PPT
27	.	.	.	_	3	punct	_

